On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Seasonal influenza epidemics impose substantial burdens on healthcare systems and cause >5 million hospitalizations of adults each year.

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Refusal of COVID-19 and influenza vaccinations was higher among White patients at an allergy/immunology clinic with a diverse ...

Animal health companies are developing vaccines that improve the breadth and effectiveness of protection against avian ...

Influenza and 2023 to 2024 COVID-19 vaccination coverage is 80.7% and 15.3%, respectively, among health care personnel at acute care hospitals and is lower among health care personnel at nursing homes ...

from one of Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk population group for influenza. Here at Sanofi, we strive to bring immunizations to ...

The following is a summary of “Influenza epidemiology and vaccine effectiveness during the 2023/2024 season in Italy: A ...

The first inactivated influenza vaccine was monovalent (influenza A). In 1942, a bivalent vaccine was produced after the discovery of influenza B. It was later discovered that influenza viruses ...

Two strains of influenza A, H1N1 and H3N2, affect people. Scientists always include these strains in the annual flu vaccine. Influenza A viruses are the ones that have been responsible for global ...